To study the role of Eladi Kwatha with Sharkara and Madhu in atyadhik yonigata raktastrava with special reference to Abnormal uterine bleeding

Not yet recruiting

• Conditions: Endocrine disorder, unspecified. Ayurveda Condition: Yonipravaha (Abnormal Uterine Bleeding),

• Registration Number: CTRI/2021/05/033360
• Lead Sponsor: Kalyani Mitalkumar Mahajan

Brief Summary

TITLE - An open label single arm clinical study of Eladi Kwatha with Sharkara and Madhu in Yonipravaha with special reference to abnormal uterine bleeding

Study design - an open label single arm clinical study

SAMPLE SIZE - 30

SAMPLING METHOD - Sequential Sampling



INCLUSION CLITERIA -Patients between the age group 15-45 yrs

Both married and unmarried women

Patients having Abnormal Uterine Bleeding with excessive and prolonged menstrual bleeding



EXCLUSION CLITERIA - Patients taking anti coagulation therapy and having any coagulation defect.

Patients with severe malnutrition and severe anemia (Hb ≤ 8 gm/dl).

Threatened, spontaneous or incomplete abortion/ectopic pregnancy,

trophoblastic diseases, placental abnormalities and Antepartum Hemorrhage.

Patients with systemic diseases like uncontrolled D.M. and T.B.

History of documented vascular disease like coronary artery disease,

cerebrovascular disease or stroke, transient ischemic attack, peripheral

vascular disease and DVT.

Condition like endometrial cancer of cervix, etc.

Bleeding from Reproductive Track due to traumatic causes, motor vehicle

accident and IC



WITHDRAWAL CLITERIA -  Patients not willing for further trial.

- If patient develops any adverse effect.

- If bleeding increases during trial.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2021-03-05
• Study Start: 2021-05-15

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: Female
• Target Recruitment: 30

Inclusion Criteria

Patients between the age group 15-45 yrs Both married and unmarried women Patients having Abnormal Uterine Bleeding with excessive and prolonged menstrual bleeding.

Exclusion Criteria

• Patients taking anti coagulation therapy and having any coagulation defect.
• Patients with severe malnutrition and severe anemia (Hb ≤ 8 gm/dl).
• Threatened, spontaneous or incomplete abortion/ectopic pregnancy, trophoblastic diseases, placental abnormalities and Antepartum Hemorrhage.
• Patients with systemic diseases like uncontrolled D.M. and T.B. History of documented vascular disease like coronary artery disease, cerebrovascular disease or stroke, transient ischemic attack, peripheral vascular disease and DVT.
• Condition like endometrial cancer of cervix, etc.
• Bleeding from Reproductive Track due to traumatic causes, motor vehicle accident and IC.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To study the efficacy of Eladi Kwatha with Sharkara and Madhu in	day 1 to day 5 of Abnormal uterine bleeding
Yonipravaha.	day 1 to day 5 of Abnormal uterine bleeding

Secondary Outcome Measures

Name	Time	Method
Adverse effect of drug Eladi Kwatha with Sharkara and Madhu will be	observed during clinical study, if any.

Trial Locations

Locations (1)

Sane Guruji Arogya Kendra; 🇮🇳 Pune, MAHARASHTRA, India

Sane Guruji Arogya Kendra

🇮🇳Pune, MAHARASHTRA, India

Dr Kalyani Mitalkumar Mahajan

Principal investigator

8983460329

mkrushna002@gmail.com